Atossa Therapeutics
Stock Forecast, Prediction & Price Target

Atossa Therapeutics Financial Estimates

Atossa Therapeutics Revenue Estimates

Atossa Therapeutics EBITDA Estimates

Atossa Therapeutics Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $54.46M
Low: $54.46M
High: $54.46M
avg. 0%
Avg: $121.27M
Low: $121.27M
High: $121.27M
avg. 122.67%
Avg: $341.03M
Low: $341.03M
High: $341.03M
avg. 181.21%
Net Income
 
% change YoY
$-20.60M
 
N/A
$-26.22M
 
-27.28%
$-30.09M
 
-14.73%
Avg: $-35.64M
Low: $-39.08M
High: $-31.52M
avg. -18.45%
Avg: $-1.71M
Low: $-34.04M
High: $83.21M
avg. 95.20%
Avg: $51.27M
Low: $51.27M
High: $51.27M
avg. 3097.87%
Avg: $180.29M
Low: $180.29M
High: $180.29M
avg. 251.63%
EBITDA
 
% change YoY
$-20.49M
 
N/A
$-27.69M
 
-35.09%
$-31.35M
 
-13.22%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$0.18
 
N/A
-$0.21
 
-16.66%
-$0.24
 
-14.28%
Avg: -$0.28
Low: -$0.31
High: -$0.25
avg. -14.58%
Avg: $0.06
Low: -$0.27
High: $0.66
avg. 120.60%
Avg: $0.41
Low: $0.41
High: $0.41
avg. 617.61%
Avg: $1.43
Low: $1.43
High: $1.43
avg. 251.63%
Operating Expenses
 
% change YoY
$20.52M
 
N/A
$27.69M
 
34.93%
$31.37M
 
13.31%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Atossa Therapeutics stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 856.56% in 2025-2028.

We have gathered data from 2 analysts. Their low estimate is -39.08M, average is -35.64M and high is -31.52M.

What is Atossa Therapeutics stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 75.97% in 2025-2028.

We have gathered data from 4 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.

What is Atossa Therapeutics stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 243.81% in 2025-2028.

We have gathered data from 2 analysts. Their low earnings per share estimate is -$0.31, average is -$0.28 and high is $-0.25.

What is the best performing analyst?

In the last twelve months analysts have been covering Atossa Therapeutics stock. The most successful analyst is Louise Chen.